PHS
LUNG icon

PFM Health Sciences’s Pulmonx LUNG Stock Holding History

PFM Health Sciences’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-368,929
Closed -$3.06M – 97
2024
Q3 		$3.06M Buy
+368,929
New +$2.67M 0.17% 60
2023
Q1 		– Sell
-1,455,770
Closed -$12.3M – 95
2022
Q4 		$12.3M Buy
1,455,770
+1,256,067
+629% +$11.9M 0.44% 64
2022
Q3 		$3.33M Buy
+199,703
New +$3.68M 0.12% 79
2022
Q1 		– Sell
-209,193
Closed -$6.71M – 72
2021
Q4 		$6.71M Buy
209,193
+72,617
+53% +$2.65M 0.23% 60
2021
Q3 		$4.91M Hold
136,576
– – 0.14% 73
2021
Q2 		$6.03M Hold
136,576
– – 0.19% 74
2021
Q1 		$6.25M Sell
136,576
-166,055
-55% -$9.52M 0.19% 78
2020
Q4 		$20.3M Buy
+302,631
New +$14.8M 0.71% 53

Other funds holding LUNG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM

PFM Health Sciences's LUNG Position: Q4 2024 in Review

PFM Health Sciences sold out of Pulmonx (LUNG) in Q4 2024, closing a stake of 368,929 shares — an estimated $3.06M sold.

PFM Health Sciences first reported a position in LUNG in Q4 2020 and held it in 8 quarters. The position peaked at $20.3M in Q4 2020. 118 funds tracked by Wall St. Rank hold LUNG as of Q4 2024.

  • PFM Health Sciences reported no remaining Pulmonx position as of Q4 2024 after selling out during the quarter.
  • PFM Health Sciences sold 368,929 Pulmonx shares in Q4 2024, an estimated $3.06M.
  • PFM Health Sciences first reported a position in Pulmonx in Q4 2020 and held it in 8 quarters.
  • PFM Health Sciences's Pulmonx position peaked at $20.3M in Q4 2020.
  • 118 funds tracked by Wall St. Rank held Pulmonx as of Q4 2024.

Based on PFM Health Sciences's 13F filing for Q4 2024, filed 14 Feb 2025.